Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Blanco

Showing results (231-240 of 256) with videos related to

Pageof 26
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|January 9, 2023
Treatment and prevention of monkeypoxFernando de la Calle-Prieto, Miriam Estébanez Muñoz, Germán Ramírez, et al.
Infectious Diseases and Therapy|September 15, 2025
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?Abiu Sempere, Rodrigo Alonso, Leire Berrocal, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2024
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective studyAinoa Ugarte, Lorena De La Mora, Elisa De Lazzari, et al.
Journal of Cardiology|December 24, 2014
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factorsAna María Pello, Carmen Cristóbal, Nieves Tarín, et al.
Open Forum Infectious Diseases|August 4, 2023
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 10, 2026
Retention in HIV Care and Immunovirological Outcomes Among Migrants and Non-Migrants: A 24-Year Cohort Study in BarcelonaAlexy Inciarte, Elizabeth Zamora-Clemente, Leire Berrocal, et al.
Vaccines|December 24, 2025
Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024)Pere Medina, Elisa de Lazzari, Mateu Espasa, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 17, 2014
[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]Javier Higueras, José Luis Martín-Ventura, Luis Blanco-Colio, et al.
BMC Cancer|July 29, 2025
Current practices in HPV-related anogenital neoplasia care in Europe - a survey analysisMayura Nathan, Kimon Chatzistamatiou, Niccolo Gallio, et al.
Pageof 26

Showing results (231-240 of 256) with videos related to

Sort By:
Pageof 26
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|January 9, 2023
Treatment and prevention of monkeypoxFernando de la Calle-Prieto, Miriam Estébanez Muñoz, Germán Ramírez, et al.
Infectious Diseases and Therapy|September 15, 2025
The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?Abiu Sempere, Rodrigo Alonso, Leire Berrocal, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2024
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective studyAinoa Ugarte, Lorena De La Mora, Elisa De Lazzari, et al.
Journal of Cardiology|December 24, 2014
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factorsAna María Pello, Carmen Cristóbal, Nieves Tarín, et al.
Open Forum Infectious Diseases|August 4, 2023
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 10, 2026
Retention in HIV Care and Immunovirological Outcomes Among Migrants and Non-Migrants: A 24-Year Cohort Study in BarcelonaAlexy Inciarte, Elizabeth Zamora-Clemente, Leire Berrocal, et al.
Vaccines|December 24, 2025
Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024)Pere Medina, Elisa de Lazzari, Mateu Espasa, et al.
Hepatology (Baltimore, Md.)|December 18, 2008
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patientsMontserrat Laguno, Carmen Cifuentes, Javier Murillas, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 17, 2014
[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]Javier Higueras, José Luis Martín-Ventura, Luis Blanco-Colio, et al.
BMC Cancer|July 29, 2025
Current practices in HPV-related anogenital neoplasia care in Europe - a survey analysisMayura Nathan, Kimon Chatzistamatiou, Niccolo Gallio, et al.
Pageof 26